Intravenous Immunoglobulin as a treatment for SLE with severe, refractory cutaneous involvement requiring hospitalization (Sengupta et al., 2023) | NobleID
v1
Intravenous Immunoglobulin as a treatment for SLE with severe, refractory cutaneous involvement requiring hospitalization (Sengupta et al., 2023)
